Polymyositis
📧 Sign up to get email alerts when something new happens for Polymyositis.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2026-07-24Clinical Trial Update: A Study to Investigate the Efficacy and Safety of Efgartigimod PH20 SC in Adult Participants With Active Idiopathic Inflammatory Myopathy. [Phase 2, Phase 3]
A Phase 2/3 trial evaluating the efficacy and safety of Efgartigimod PH20 SC in adults with active idiopathic inflammatory myopathy has comp…
-
CLINICAL_TRIALS trial_result · 2026-04-27Clinical Trial Update: Safety and Efficacy of ULSC on Disease Severity and Steroid Tapering in Participants With Dermatomyositis/ Polymyositis (DM/PM), Also Known as Idiopathic Inflammatory Myopathy (IIM) [Phase 2, Phase 3]
A Phase 2/3 clinical trial update reports on safety and efficacy of ULSC for reducing disease severity and enabling steroid tapering in Derm…
-
CLINICAL_TRIALS research · 2026-04-24Clinical Trial Update: Environmental Risk Factors for Myositis in Military Personnel
A completed NIEHS-sponsored clinical study evaluated environmental risk factors for myositis in military personnel, including dermatomyositi…
-
CLINICAL_TRIALS research · 2026-04-24Clinical Trial Update: Adult and Juvenile Myositis
This entry reports that a NIEHS-sponsored clinical trial investigating adult and juvenile myositis is currently recruiting for dermatomyosit…
-
CLINICAL_TRIALS research · 2026-04-23Clinical Trial Update: A Study to Understand How the Study Medicine (PF-06823859) Works in People With Active Idiopathic Inflammatory Myopathies [Dermatomyositis (DM) and Polymyositis (PM)] [Phase 3]
Pfizer is conducting a Phase 3 trial of PF-06823859 to study its effects in people with active idiopathic inflammatory myopathies, specifica…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2026-04-23Clinical Trial Update: A Study to Assess the Long-term Safety and Efficacy of a Subcutaneous Formulation of Efgartigimod in Adults With Active Idiopathic Inflammatory Myopathy [Phase 3]
A Phase 3 trial evaluating the long-term safety and efficacy of a subcutaneous formulation of efgartigimod in adults with active idiopathic …
-
CLINICAL_TRIALS research · 2026-04-21Clinical Trial Update: A Study to Investigate the Efficacy and Safety of Anifrolumab Administered as Subcutaneous Injection and Added to Standard of Care Compared With Placebo Added to Standard of Care in Adult Participants With Idiopathic Inflammatory Myopathies (Polymyositis and Dermatomyositis) [Phase 3]
A Phase 3 trial to evaluate the efficacy and safety of subcutaneous anifrolumab added to standard of care versus placebo with standard of ca…
-
CLINICAL_TRIALS research · 2026-04-20Clinical Trial Update: Environmental Risk Factors for the Anti-synthetase Syndrome
This NIEHS-sponsored clinical trial investigates environmental risk factors for anti-synthetase syndrome, enrolling patients with inflammato…
-
CLINICAL_TRIALS research · 2026-04-07Clinical Trial Update: A Study to Understand How the Study Medicine Dazukibart Works in People With Idiopathic Inflammatory Myopathies [Phase 3]
This is a Phase 3 clinical trial investigating how the study drug Dazukibart works in people with Dermatomyositis and Polymyositis, with rec…
-
CLINICAL_TRIALS trial_result · 2026-03-31Clinical Trial Update: Diagnostic Accuracy of Whole Body Magnetic Resonance Imaging in Inflammatory Myopathies [NA]
A completed clinical trial evaluating the diagnostic accuracy of whole-body magnetic resonance imaging for detecting inflammatory myopathies…
-
CLINICAL_TRIALS research · 2026-03-30Clinical Trial Update: Safety and Efficacy of ULSC on Disease Severity and Steroid Tapering in Participants With Dermatomyositis/ Polymyositis (DM/PM), Also Known as Idiopathic Inflammatory Myopathy (IIM) [Phase 2, Phase 3]
The sponsor reports an ongoing Phase 2/3 trial assessing the safety and efficacy of ULSC in reducing disease severity and aiding steroid tap…
-
CLINICAL_TRIALS trial_result · 2026-03-23Clinical Trial Update: Muscle Function and Effects of Repetitive Task Training in Patients With Inflammatory Myopaties [NA]
This completed clinical trial evaluated muscle function and the effects of repetitive task training in patients with inflammatory myopathies…
-
CLINICAL_TRIALS research · 2026-02-27Clinical Trial Update: Add-on Intravenous Immunoglobulins in Early Myositis [Phase 2, Phase 3]
A Phase 2/Phase 3 add-on intravenous immunoglobulin study for early inflammatory myopathies (myositis) is active but not currently recruitin…
-
CLINICAL_TRIALS research · 2026-02-17Clinical Trial Update: Studies of the Natural History and Pathogenesis of Autoimmune/Connective Tissue Diseases
This Clinical Trial Update notes that studies on the natural history and pathogenesis of autoimmune and connective tissue diseases have comp…
-
CLINICAL_TRIALS research · 2026-02-13Clinical Trial Update: Rheumatology Patient Registry and Biorepository
This Clinical Trial Update describes a Yale University-led rheumatology patient registry and biorepository that is currently recruiting to c…
-
CLINICAL_TRIALS research · 2026-01-28Clinical Trial Update: MIHRA - Patient-Rooted Insights for Shaping Myositis Science (PRISMS)
The MIHRA PRISMS clinical study for myositis is currently recruiting, sponsored by the Myositis International Health & Research Collaborativ…
-
CLINICAL_TRIALS trial_result · 2025-12-22Clinical Trial Update: Efficacy of an Individual Rehabilitation Program in Polymyositis and Dermatomyositis [Phase 2]
Phase 2 study evaluating an individual rehabilitation program for polymyositis and dermatomyositis has completed and reported efficacy resul…
-
CLINICAL_TRIALS research · 2025-09-30Clinical Trial Update: CAR-T Cells in Systemic B Cell Mediated Autoimmune Disease [Phase 1, Phase 2]
Miltenyi Biomedicine is conducting Phase 1/2 trials of CAR-T cell therapy targeting B cells for autoimmune diseases, including systemic lupu…
-
CLINICAL_TRIALS research · 2025-08-14Clinical Trial Update: Phase 2 Trial to Evaluate the Efficacy, Safety of Allogeneic Mitochondria (PN-101) in Patients With Refractory Polymyositis or Dermatomyositis [Phase 2]
A Phase 2 clinical trial is planned to evaluate the efficacy and safety of PN-101, an allogeneic mitochondrial therapy, in patients with ref…
-
CLINICAL_TRIALS other · 2025-07-23Clinical Trial Update: A Study to Investigate the Efficacy and Safety of Efgartigimod PH20 SC in Adult Participants With Active Idiopathic Inflammatory Myopathy. [Phase 2, Phase 3]
A Phase 2/Phase 3 clinical trial is evaluating the efficacy and safety of subcutaneous Efgartigimod PH20 (efgartigimod alfa) in adults with …
-
CLINICAL_TRIALS withdrawal · 2025-07-17Clinical Trial Update: Study of M5049 in DM and PM Participants (NEPTUNIA) [Phase 2]
A Phase 2 trial (NEPTUNIA) evaluating M5049 for Dermatomyositis and Polymyositis has been terminated.
-
CLINICAL_TRIALS trial_result · 2025-06-03Clinical Trial Update: Efficacy and Safety of Longidaza® for the Treatment of Patients With Residual Changes in the Lungs After COVID-19 [Phase 3]
A Phase 3 study evaluating the efficacy and safety of Longidaza for residual lung changes after COVID-19 has completed.
-
CLINICAL_TRIALS research · 2025-04-11Clinical Trial Update: Anti-CD19 CAR T-Cell Therapy in Refractory Systemic Autoimmune Diseases [Phase 1, Phase 2]
Clinical trial update for anti-CD19 CAR T-cell therapy being explored in refractory systemic autoimmune diseases, including systemic lupus e…
-
CLINICAL_TRIALS research · 2025-03-21Clinical Trial Update: Mesenchymal Stem Cells Infusion in Patients With Autoimmune Diseases [Phase 1, Phase 2]
Ongoing Phase 1/Phase 2 clinical trial updates describe infusion of mesenchymal stem cells in multiple autoimmune diseases and indicate the …
-
CLINICAL_TRIALS trial_result · 2025-01-24Clinical Trial Update: Phase 1 Study of ULSC in Patients With Polymyositis (PM) and Dermatomyositis (DM) [EARLY_Phase 1]
A Phase 1 study evaluating ULSC in patients with polymyositis and dermatomyositis has completed.